DK0670904T3 - Vector for expression of therapeutically relevant genes - Google Patents

Vector for expression of therapeutically relevant genes

Info

Publication number
DK0670904T3
DK0670904T3 DK94900042T DK94900042T DK0670904T3 DK 0670904 T3 DK0670904 T3 DK 0670904T3 DK 94900042 T DK94900042 T DK 94900042T DK 94900042 T DK94900042 T DK 94900042T DK 0670904 T3 DK0670904 T3 DK 0670904T3
Authority
DK
Denmark
Prior art keywords
vector
expression
therapeutically relevant
relevant genes
gene
Prior art date
Application number
DK94900042T
Other languages
Danish (da)
Inventor
Ulrike Stein
Wolfgang Walther
Original Assignee
Max Delbrueck Centrum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Delbrueck Centrum filed Critical Max Delbrueck Centrum
Application granted granted Critical
Publication of DK0670904T3 publication Critical patent/DK0670904T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The object of the invention is to render cancer therapy more effective, thus more successful. This object is reached by means of a vector for the expression of therapeutically relevant proteins based on constructs which are suitable for expression im mammal cells. This vector is characterized by a mdr1 promoter inducible by cytostatic agents or a defined sequence thereof, by a gene for coding a therapeutically relevant protein and possibly by mdr1 enhancer elements arranged before of after the gene.
DK94900042T 1992-11-12 1993-11-10 Vector for expression of therapeutically relevant genes DK0670904T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4238778A DE4238778C2 (en) 1992-11-12 1992-11-12 Vector for the expression of therapeutically relevant genes
PCT/DE1993/001086 WO1994011522A2 (en) 1992-11-12 1993-11-10 Vector for the expression of therapy-relevant genes

Publications (1)

Publication Number Publication Date
DK0670904T3 true DK0670904T3 (en) 2003-07-14

Family

ID=6473100

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94900042T DK0670904T3 (en) 1992-11-12 1993-11-10 Vector for expression of therapeutically relevant genes

Country Status (6)

Country Link
EP (1) EP0670904B1 (en)
JP (1) JPH09504161A (en)
AT (1) ATE234929T1 (en)
DE (2) DE4238778C2 (en)
DK (1) DK0670904T3 (en)
WO (1) WO1994011522A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID24500A (en) * 1996-10-18 2000-07-20 Canji Inc METHODS AND COMPOSITIONS FOR DELIVERING AND MARKING INTERFERON-ALPHA NUCLEIC ACIDS
DE19860602A1 (en) * 1998-12-29 2000-07-06 Max Delbrueck Centrum Gene transfer vector for the diagnosis and therapy of malignant tumors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339654C (en) * 1988-06-03 1998-02-03 Ursula A. Germann Gene therapy using gene fusion for genetic or acquired disorders

Also Published As

Publication number Publication date
EP0670904B1 (en) 2003-03-19
WO1994011522A3 (en) 1994-09-29
DE59310334D1 (en) 2003-04-24
WO1994011522A2 (en) 1994-05-26
DE4238778A1 (en) 1994-05-19
DE4238778C2 (en) 1995-11-02
JPH09504161A (en) 1997-04-28
EP0670904A1 (en) 1995-09-13
ATE234929T1 (en) 2003-04-15

Similar Documents

Publication Publication Date Title
FI951404A (en) Adenovirus vectors to transmit foreign genes to the central nervous system, especially the brain, cells
ES2127831T3 (en) MULTICISTRONIC EXPRESSION UNITS AND THEIR APPLICATION.
DE69114299D1 (en) METHOD AND COMPOSITIONS FOR GENE THERAPY AND STRENGTHENING THE IMMUNE SYSTEM.
SE8004066L (en) PLASMIDES, THEIR PREPARATION, THEIR USE AS VECTORS, THEREFORE RECEIVED CELLS AND THEIR USE
AU1955388A (en) Method for potentiating and inhibiting insulin-like growth factor activity
NO981353D0 (en) Regulated genes and uses thereof
PT662137E (en) TRANSCRIPTION OF GENES AND IONIZING RADIATION: METHODS AND COMPOSITIONS
EP1017797A4 (en) Non-primate lentiviral vectors and packaging systems
FI972293A0 (en) Foerfaranden Foer sameexpression av mera aen en gen
NO990086D0 (en) Truncated, soluble tumor necrosis factor receptors of type I and type II
DK0832258T3 (en) Upstream activator sequences and recombinant promoter sequences that are functional in Yarrowia and vectors containing these
FI941048A (en) DNA sequences encoding gelonin polypeptide
WO1997022695A3 (en) Nucleotide sequences, proteins, drugs and diagnostic agents for treating cancer
DE69830910D1 (en) KALIUM CHANNEL PROTEINS FOR USE IN GENE THERAPY TO REDUCE ECG DYSFUNCTION
FI961202A (en) Grb3-3 gene, its variants and their uses
DK0670904T3 (en) Vector for expression of therapeutically relevant genes
DK0817858T3 (en) Vectors containing therapeutic genes for antimicrobial peptides for use in gene therapy
ATE315094T1 (en) SELF-DELELETING VECTORS FOR CANCER THERAPY
DK0781344T3 (en) Newly known implant and novel vector for the treatment of acquired diseases
HUP9904235A2 (en) Novel constructs and vectors for the targeted and inducible expression of genes
DE59510829D1 (en) GENE THERAPEUTIC METHOD USING DNA VECTORS WITHOUT SELECTION MARKER GENE
ATE288488T1 (en) COMPOSITIONS AND METHODS FOR ELIMINATING UNDESIRABLE CELLS
HUP0004857A2 (en) D-amino acid oxidase promoter from t. variabilis
ES2107997T3 (en) PROCEDURE FOR USE OF EUCHARIOTIC EXPRESSION VECTORS THAT INCLUDE THE BK VIRUS ENHANCER.
WO2000053789A3 (en) Retroviral expression vectors on the basis of herv- long terminal repeat sequences